Natco Pharma has issued a clarification regarding ongoing litigation and its potential impact on the company’s financial performance. While the litigation is still in progress, the outcome is awaited and will be communicated to the stock exchanges in due course, based on its material impact. Currently, the company states that there is no material financial impact from the litigation.
Update on Litigation Status
Natco Pharma has addressed concerns regarding ongoing litigation, clarifying that the proceedings are continuing. The outcome of the litigation is still pending. Upon resolution, Natco Pharma will inform the stock exchanges about any significant impact on its financial standing.
Material Financial Impact Assessment
As of January 7, 2026, Natco Pharma reports that there is no material financial impact on the company resulting from this particular article. The company continues to make the required disclosures to the Stock Exchange.
Source: BSE
